Keywords: Novartis, Lucentis, UK, NICE, DME, Diabetic macular edema

UK's NICE final guidance on Novartis' Lucentis for diabetic macular edema positive

Article | 03 January 2013

Print This

In final draft guidance issued today (4 January), the UK’s drug watchdog the National Institute for Health and Clinical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in